Evaluating a new protocol for treating biliary atresia after surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients who have undergone Kasai surgery for biliary atresia at the Institute of Liver and Biliary Sciences. It includes both a retrospective historical cohort and a prospective cohort to assess the efficacy of a new post-surgery protocol. The study will monitor liver function tests and other health indicators weekly for the first month, then bi-weekly and monthly for up to one year. Statistical analyses will be conducted to evaluate the outcomes of the new protocol compared to historical controls.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Post Kasai Biliary atresia operated at ILBS with retrospective historical cohort (Jan 2015 to Dec 2017) and retrospective + prospective cohort with new protocol (Jan 2018 till June 2024).

Exclusion Criteria:

1. Subjects having major surgical complications
2. Defaulters or Patient not following protocol/not giving consent
3. Biliary atresia splenic malformation

Where it's running

• Institute of Liver & Biliary Sciences
  New Delhi, Delhi, India Recruiting

Study contacts

• Study coordinator: Dr Anmol Anmol, MD
• Email: dranmol1991@gmail.com
• Phone: 01146300000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Umbilical cord stem cells added during Kasai to help biliary atresia

  This early-stage trial tests whether injecting umbilical cord mesenchymal stem cells during Kasai portoenterostomy is safe and helpful for infants with biliary atresia.

  Recruiting Phase 1 Dr Cipto Mangunkusumo General Hospital · Jakarta Pusat, DKI Jakarta · NCT07797673

• See if a computer program can help diagnose cholestasis in newborns using parent-provided stool images

  A computer program is being tested to see if it can correctly identify cholestasis and biliary atresia in newborns by analyzing stool images provided by parents.

  Recruiting Birmingham Women's and Children's NHS Foundation Trust · Birmingham · NCT07697872

• Indocyanine green for diagnosing biliary atresia

  This test tries to see if a harmless fluorescent dye (indocyanine green) can show whether infants under 3 months with cholestasis have blocked bile ducts (biliary atresia).

  Recruiting Phase 1/2 Boston Children's Hospital · Boston, Massachusetts · NCT07513038

• Using near-infrared ICG dye to check bile flow in newborns with cholestasis

  We will give eligible newborns a single IV dose of indocyanine green (ICG) to see if the dye appears in their diapers, which would indicate bile is flowing and the bile ducts are open.

  Recruiting Early Phase 1 University of Alabama at Birmingham · Birmingham, Alabama · NCT07250854

• High-MCT nutritional support for infants with biliary atresia

  We will test whether giving a high medium-chain triglyceride (MCT) formula before and after Kasai surgery helps infants with biliary atresia grow better and recover faster than standard feeding.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06764082

• Using oral antibiotics to prevent cholangitis after liver surgery in infants

  This study is testing if giving oral antibiotics to infants after liver surgery can help prevent cholangitis, compared to those who don’t receive the antibiotics.

  Recruiting Children's Hospital of Fudan University · Shanghai, Shanghai Municipality · NCT05925309

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.